Biotech Late Stage Investors & VC Firms
652 firms in this list, with a median first check of $1M. 131 of them lead rounds. Generated from verified public data and updated continuously.
Samho Green Investment, Inc.
SeoulSeed–Late Stage$500K – $10M
11 people
ALIVE Israel HealthTech Fund
SavyonSeed–Late Stage
10 people
BOLD Longevity
BostonGrowth–Late Stage
10 people
Almeda Ventures
Tel AvivSeed–Late Stage
12 people
Avego BioScience Capital
AlpharettaSeries A–Late Stage
2 people
DeepTech & Climate Fonds
MunichSeed–Late Stage$5.5M – $55M
3 people
Cycad Group LLC
Santa BarbaraSeed–Late Stage
4 people
Syridex Bio
PrincetonPre-Seed–Late Stage
13 people
Ballast Point Ventures
TampaGrowth–Late Stage$5M – $15M
12 people
Avestria Ventures
San FranciscoPre-Seed–Late Stage
5 people
Evidity Health Capital
New YorkGrowth–Late Stage$5M
5 people
Kama Flow
MoscowSeed–Late Stage
2 people
atai Life Sciences
New YorkSeed–Late Stage
16 people
Wallonie Entreprendre
LiègePre-Seed–Late Stage
9 people
6 Dimensions Capital
Grand CaymanSeed–Late Stage
17 people
Recharge Thematic Ventures Management Llc
New YorkSeed–Late Stage
8 people
Alexandria
PasadenaSeed–Late Stage
1 person
Checkmate Capital Group LLC
PasadenaSeed–Late Stage
7 people
QC·VENTURES
ViennaSeed–Late Stage$216K – $4.3M
7 people
Sectoral Asset Management
MontrealSeries A–Late Stage
9 people
20/20 HealthCare Partners LLC
AuburndaleSeed–Late Stage
7 people
University of Cambridge Enterprise
CambridgePre-Seed–Late Stage
10 people
Clal Biotechnology Industries
Tel AvivSeed–Late Stage
9 people
Vesalius Biocapital III Partners SàRL
ConternSeed–Late Stage$10.8M
12 people
Related lists
Late Stage Investors & VC Firms (2974)Biotech Investors & VC Firms (2185)Biotech Seed Investors & VC Firms (1824)Late Stage Investors & VC Firms in North America (1695)Biotech Series A Investors & VC Firms (1668)Late Stage Investors & VC Firms in United States (1516)Biotech Investors & VC Firms in North America (1391)Biotech Investors & VC Firms in United States (1267)Late Stage Investors & VC Firms in Europe (965)Biotech Pre-Seed Investors & VC Firms (957)
Data sourced from public filings and firms' own websites — see our methodology.














































































_edited.jpg)





